Discover how lightweight, stateless Thin Clients with read-only OS architectures support compliance, extend hardware lifespan ...
Software maker Ivanti is urging users of its end-point security product to patch a critical vulnerability that makes it possible for unauthenticated attackers to execute malicious code inside affected ...
Phase 2 (Actuate-1801 Part 3B) trial meets primary endpoint and demonstrates a clinically meaningful increase in median overall survival (10.1 months vs 7.2 months; log-rank p=0.01) in previously ...
ST. HELIER, Jersey & SHANGHAI, China & SAN FRANCISCO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR), a global oncology company working to extend survival in some of the most aggressive ...
End-of-Phase 2 interactions with FDA complete; scientific advice received from EMA –– Company expects to dose first patient in global Phase 3 ...
CHICAGO and FORT WORTH, Texas, May 31, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback